- Country: Ukraine
- Summary: Bupivacaine, Solution for Injection, 5 Mg/Ml, 5 Ml Each; Bupivacaine, Solution for Injection, 2.5 Mg/Ml in 200 Ml; Ropivacaine, Solution for Injection, 7.5 Mg/Ml, 10 Ml Each; Omeprazole 40 Mg Bottle; Ondansetron Solution...
- UAT Ref No: 133391792
- Deadline: 10 Jan 2026
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: UAH 2933000
- Notice Type: Tender
- Document Ref. No.: UA-2026-01-07-001695-a
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Bupivacaine, solution for injection, 5 mg/ml, 5 ml each; Bupivacaine, solution for injection, 2.5 mg/ml in 200 ml; Ropivacaine, solution for injection, 7.5 mg/ml, 10 ml each; Omeprazole 40 mg bottle; Ondansetron solution for injection 2 mg/ml in 2 ml; Sevoflurane solution for inhalation 100% 250 ml, bottle; Paracetamol solution for infusions 10 mg/ml 100 ml; Enoxaparin sodium, solution for injection, 10,000 anti-Xa IU/ml, 0.2 ml each; Tranexamic acid solution for injection, 100 mg/ml in 10 ml; Theophylline solution for injections 20 mg/ml in 5 doses ml; Glucose solution for infusions 5% in 400 ml; Glucose solution for infusions 5% in 200 ml; Glucose solution for infusions 10% in 200 ml; Sodium chloride, solution for infusions, 9 mg/ml 100 ml; Sodium chloride, solution for infusions, 9 mg/ml 200 ml; Sodium chloride, solution for infusion, 9 mg/ml 500 ml; Ringer Lactate solution for infusions of 400 ml; Sodium bicarbonate solution for infusions 40 mg/ml 100 ml; Calcium gluconate solution for injection 100 mg/ml in 5 ml; Magnesium sulfate, solution for injection, 250 mg/ml, 5 ml each; Cefazolin, powder for injections of 1 g; Piperacillin/tazobactam, powder (lyophilisate) for solution, 4 g/0.5 g each; Cefotaxime, powder for injections of 1 g; Ceftriaxone, powder for injections of 1 g; Vancomycin lyophilisate/powder for solution for infusion 1000 mg; Ciprofloxacin solution for infusions, 2 mg/ml per 100 ml; Levofloxacin solution for infusions, 5 mg/ml, 150 ml; Ofloxacin, solution for infusions, 2 mg/ml, 100 ml each; Cefepime, powder for injection 1.0; Metronidazole, solution for infusion, 5 mg... Type of purchase: goods Classifier and its corresponding code: DK 021:2015: 33600000-6 — Pharmaceutical products The term (term) of delivery of the Goods is no later than 10 calendar days from the moment of receiving the order for the Goods. The relevant term may be changed upon agreement of the parties. The goods are delivered in batches according to the quantity specified by t...
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINBupivacaine, Solution for Injection, 5 Mg/Ml, 5 Ml Each; Bupivacaine, Solution for Injection, 2.5 Mg/Ml in 200 Ml; Ropivacaine, Solution for Injection, 7.5 Mg/Ml, 10 Ml Each; Omeprazole 40 Mg Bottle; Ondansetron Solution... - Ukraine Tender
The COMMUNAL NON-PROFIT ENTERPRISE "TERNOPIL REGIONAL CLINICAL PERINATAL CENTER "MOTHER AND CHILD" OF THE TERNOPIL REGIONAL COUNCIL", a Government sector organization in Ukraine, has announced a new tender for Bupivacaine, Solution for Injection, 5 Mg/Ml, 5 Ml Each; Bupivacaine, Solution for Injection, 2.5 Mg/Ml in 200 Ml; Ropivacaine, Solution for Injection, 7.5 Mg/Ml, 10 Ml Each; Omeprazole 40 Mg Bottle; Ondansetron Solution.... This tender is published on UkraineTenders under UAT Ref No: 133391792 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2026-01-10.
The estimated tender value is UAH 2933000, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
